NO862353L - Human tumornekrosefaktor. - Google Patents

Human tumornekrosefaktor.

Info

Publication number
NO862353L
NO862353L NO86862353A NO862353A NO862353L NO 862353 L NO862353 L NO 862353L NO 86862353 A NO86862353 A NO 86862353A NO 862353 A NO862353 A NO 862353A NO 862353 L NO862353 L NO 862353L
Authority
NO
Norway
Prior art keywords
human tumor
tumor cancer
cancer factor
factor
human
Prior art date
Application number
NO86862353A
Other languages
English (en)
Other versions
NO174970C (no
NO174970B (no
NO862353D0 (no
Inventor
David Fu Chi Mark
Martha Ballie Ladner
Leo Shun Lee Lin
Alice Ming Wang
Abla Abu-Zayyad Creasey
Janelle Noble Van Arsdell
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/730,696 external-priority patent/US4677064A/en
Priority claimed from US06/760,661 external-priority patent/US4677063A/en
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of NO862353D0 publication Critical patent/NO862353D0/no
Publication of NO862353L publication Critical patent/NO862353L/no
Publication of NO174970B publication Critical patent/NO174970B/no
Publication of NO174970C publication Critical patent/NO174970C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
NO862353A 1984-10-15 1986-06-12 Rekombinant DNA, rekombinant DNA-vektor samt vertscelle NO174970C (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US66102684A 1984-10-15 1984-10-15
US67036084A 1984-11-09 1984-11-09
US06/730,696 US4677064A (en) 1984-11-09 1985-05-02 Human tumor necrosis factor
US06/760,661 US4677063A (en) 1985-05-02 1985-07-30 Human tumor necrosis factor
PCT/US1985/001921 WO1986002381A1 (en) 1984-10-15 1985-10-03 Human tumor necrosis factor

Publications (4)

Publication Number Publication Date
NO862353D0 NO862353D0 (no) 1986-06-12
NO862353L true NO862353L (no) 1986-06-12
NO174970B NO174970B (no) 1994-05-02
NO174970C NO174970C (no) 1994-08-10

Family

ID=27505306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862353A NO174970C (no) 1984-10-15 1986-06-12 Rekombinant DNA, rekombinant DNA-vektor samt vertscelle

Country Status (11)

Country Link
EP (1) EP0200748B1 (no)
JP (1) JPH0866194A (no)
AU (1) AU589919B2 (no)
BG (1) BG60238B1 (no)
DE (1) DE3581730D1 (no)
DK (1) DK279886A (no)
ES (1) ES8704547A1 (no)
FI (1) FI862531A (no)
IL (1) IL76699A (no)
NO (1) NO174970C (no)
WO (1) WO1986002381A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
EP0155549B1 (en) * 1984-03-06 1991-03-20 Dainippon Pharmaceutical Co., Ltd. Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
JPS6248634A (ja) * 1985-07-23 1987-03-03 Mochida Pharmaceut Co Ltd 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物
CA1286843C (en) * 1985-10-30 1991-07-23 Leo S. Lin Purification method for proteins
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
ATE107362T1 (de) * 1986-06-20 1994-07-15 Dainippon Pharmaceutical Co Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.
FR2601678B1 (fr) * 1986-07-18 1989-11-24 Inst Nat Sante Rech Med Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
WO1988006625A2 (en) * 1987-02-26 1988-09-07 Cetus Corporation Arginine-depleted human tumor necrosis factor
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
JPH0797997B2 (ja) * 1988-04-28 1995-10-25 帝人株式会社 新規生理活性ポリペプチド
DE3841754A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
DE3841768A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
DE3841764A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide
GB8905606D0 (en) * 1989-03-11 1989-04-26 Scras Peptides
WO1991002540A1 (en) 1989-08-16 1991-03-07 Cetus Corporation Compositions for the inhibition of protein hormone formation and uses thereof
WO1991006658A2 (en) * 1989-10-24 1991-05-16 Cetus Corporation Infective protein delivery system
PL2953634T3 (pl) 2013-02-07 2021-11-22 The General Hospital Corporation Sposoby namnażania lub zubożania limfocytów t-regulatorowych

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90047A (en) * 1982-10-19 1992-12-01 Cetus Oncology Corp Cysteine-depleted biologically active muteins other than interferon - '
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
DE3472793D1 (en) * 1983-12-26 1988-08-25 Asahi Chemical Ind A novel physiologically active polypeptide
EP0155549B1 (en) * 1984-03-06 1991-03-20 Dainippon Pharmaceutical Co., Ltd. Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
DE3517153A1 (de) * 1985-01-07 1986-07-10 Murillo Contreras, Jesús, México Feuerhemmende beschichtungsmischung und verfahren zu deren herstellung
JP2515975B2 (ja) * 1985-02-26 1996-07-10 大日本製薬株式会社 抗腫瘍作用を有するポリペプチド

Also Published As

Publication number Publication date
WO1986002381A1 (en) 1986-04-24
BG60238B1 (bg) 1994-01-24
DE3581730D1 (de) 1991-03-14
ES8704547A1 (es) 1987-04-01
BG60238B2 (bg) 1994-01-18
IL76699A (en) 1998-03-10
FI862531A0 (fi) 1986-06-13
NO174970C (no) 1994-08-10
AU5010685A (en) 1986-05-02
EP0200748A1 (en) 1986-11-12
ES547871A0 (es) 1987-04-01
IL76699A0 (en) 1986-02-28
JPH0866194A (ja) 1996-03-12
NO174970B (no) 1994-05-02
EP0200748B1 (en) 1991-02-06
DK279886D0 (da) 1986-06-13
AU589919B2 (en) 1989-10-26
NO862353D0 (no) 1986-06-12
DK279886A (da) 1986-06-13
FI862531A (fi) 1986-06-13

Similar Documents

Publication Publication Date Title
FI862094A (fi) Bornerande terapeutisk komposition.
DE3582894D1 (de) Hautbehandlungsmittel.
FI844753L (fi) Receptorsystem foer cellmatris och anvaendning daerav foer diagnosticering och behandling av cancer.
NO862353D0 (no) Human tumornekrosefaktor.
DE3689354D1 (de) Herzschrittmacher.
DE3586251D1 (de) Kosmetisches praeparat.
FI850946A0 (fi) Medicinska plaoster.
DE3689347D1 (de) Herzschrittmacher.
NO156515C (no) Hudpleiepreparat.
IT1209659B (it) Perfezionamenti riguardanti la terapia con ciclosporine.
DE3669105D1 (de) Therapeutische zusammensetzung.
FI885177A0 (fi) Foerfarande foer behandling av leukemier och vissa andra former av cancer.
FI853249A0 (fi) Cdna-kloner foer human erytropoietin.
NO880908L (no) Kombinasjonsterapi med bruk av antitumor immunotoksiner med tumornekrosefaktor.
FI850193A0 (fi) Terapeutiska lhrh analoger.
FI875039A (fi) Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
DE3650261D1 (de) Herzschrittmacher.
FI843266A (fi) Terapeutiska aemnen.
DE3670016D1 (de) Sinterverfahren.
DE3583611D1 (de) Transtrachealkatheteranordnung.
ATE60798T1 (de) Menschlicher tumornekrosisfaktor.
DE3687951D1 (de) Katheter.
DE3579213D1 (de) Beleuchtungskoerper.
SE8402273D0 (sv) Naturligt cancervardmedel celatin
FI862334A (fi) Terapeutiska kompositioner.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2001